ImmuCell Announced That It Recently Submitted The Chemistry, Manufacturing And Controls Technical Section For Re-Tain To The FDA
Portfolio Pulse from Benzinga Newsdesk
ImmuCell has submitted the Chemistry, Manufacturing and Controls technical section for Re-Tain to the FDA.
August 29, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ImmuCell's recent submission of the technical section for Re-Tain to the FDA could potentially expedite the approval process.
The submission of the technical section for Re-Tain to the FDA by ImmuCell is a crucial step in the approval process. This could potentially expedite the approval process, which would be beneficial for the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100